|
TM2D2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-15 |
| Normal-vs-Stage2 |
6.49289999987701E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
1.252190E-01 |
| Stage1-vs-Stage3 |
1.330420E-02 |
| Stage1-vs-Stage4 |
6.86659999971084E-08 |
| Stage2-vs-Stage3 |
1.264060E-03 |
| Stage2-vs-Stage4 |
5.60010000039135E-07 |
| Stage3-vs-Stage4 |
5.039400E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.90130000002442E-06 |
| Normal-vs-Asian |
2.47124543051314E-12 |
| Caucasian-vs-AfricanAmerican |
2.626400E-01 |
| Caucasian-vs-Asian |
8.100200E-01 |
| AfricanAmerican-vs-Asian |
4.245400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.870400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
1.89415150231298E-12 |
| Normal-vs-Age(81-100Yrs) |
2.373100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.604400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.718800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.386400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.214800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.831400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.117200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.9367000032905E-08 |
| Classical-VS-Follicular |
2.904100E-03 |
| Classical-VS-Other |
9.218200E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
5.76779957128792E-10 |
| Tall-VS-Other |
3.627400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.037600E-01 |
| Follicular-VS-Normal |
3.77700000053771E-07 |
| Other-VS-Normal |
3.390100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79056769411545E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.60460000526209E-08 |
|
|
